Cargando…

The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study

BACKGROUND: The risk of cardiovascular disease is tremendously high in dialysis patients. Dialysis patients treated with vitamin D analogs show decreased cardiovascular morbidity and mortality compared with untreated patients. We examined the influence of two common vitamin D analogs, alfacalcidol a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Ditte, Rasmussen, Knud, Rasmussen, Lars M, Bruunsgaard, Helle, Brandi, Lisbet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136403/ https://www.ncbi.nlm.nih.gov/pubmed/25112372 http://dx.doi.org/10.1186/1471-2369-15-130

Ejemplares similares

Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol
por: Hansen, Ditte, et al.
Publicado: (2009)

Effects of High Doses of Cholecalciferol in Normal Subjects: A Randomized Double-Blinded, Placebo-Controlled Trial
por: Nygaard, Birgitte, et al.
Publicado: (2014)

Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial
por: Bressendorff, Iain, et al.
Publicado: (2016)

The Effect of High Dose Cholecalciferol on Arterial Stiffness and Peripheral and Central Blood Pressure in Healthy Humans: A Randomized Controlled Trial
por: Bressendorff, Iain, et al.
Publicado: (2016)

N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
por: Ducros, Jacques, et al.
Publicado: (2020)

The effect of magnesium supplementation on vascular calcification in chronic kidney disease—a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale
por: Bressendorff, Iain, et al.
Publicado: (2017)

Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients
por: Wang, Yaqiong, et al.
Publicado: (2021)

Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet
por: Lentz, Katrine Aagaard, et al.
Publicado: (2022)

The effect of oral vitamin D on serum level of N-terminal pro-B-type natriuretic peptide
por: Seirafian, Shiva, et al.
Publicado: (2014)

N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients
por: Ikeda, Misa, et al.
Publicado: (2016)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2015)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Causes of Vitamin K Deficiency in Patients on Haemodialysis
por: Wikstrøm, Signe, et al.
Publicado: (2020)

Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis
por: Chen, Lan, et al.
Publicado: (2017)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

The Use of N-Terminal Pro-Brain Natriuretic Peptide to Evaluate Vascular Disease in Elderly Patients with Mental Illness
por: Nilsson, Karin, et al.
Publicado: (2012)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
por: Reynen, Stefanie, et al.
Publicado: (2021)

N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population
por: Lee, Kyung-Hoon, et al.
Publicado: (2010)

Prognostic value of amino terminal pro-b-type natriuretic peptide in septic patients
por: Maroto, Fernando, et al.
Publicado: (2008)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
por: Zachariah, Justin P, et al.
Publicado: (2016)

Predictive abilities of baseline measurements of fluid overload, assessed by bioimpedance spectroscopy and serum N-terminal pro-B-type natriuretic peptide, for mortality in hemodialysis patients
por: Siriopol, Ianis, et al.
Publicado: (2017)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Correlation of Vitamin D Deficiency With Severity of Chronic Heart Failure as Assessed by Functional Class and N-Terminal Pro-Brain Natriuretic Peptide Levels
por: Otaal, Parminder S, et al.
Publicado: (2021)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Predictive value of N-terminal pro-brain natriuretic peptide among critically ill patients
por: Cubrilo-Turek, M, et al.
Publicado: (2012)

Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome
por: Bao, Yuanyuan, et al.
Publicado: (2011)

Comparison of N-Terminal Pro B-Natriuretic Peptide and Echocardiographic Indices in Patients with Mitral Regurgitation
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2010)

Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery
por: Liu, Hua, et al.
Publicado: (2013)

Plasma N-Terminal Pro B-Type Natriuretic Peptide Concentrations in Dogs with Pulmonic Stenosis
por: KOBAYASHI, Keiya, et al.
Publicado: (2014)

N-terminal pro-B-type natriuretic peptide in patients after cervical spine surgery
por: Spatenkova, V, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_h3562d163isoh78attv2amfosg